PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.95 CHF 4.1% Market Closed
Market Cap: 921.9m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PolyPeptide Group AG
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Cash & Cash Equivalents
€95.7m
CAGR 3-Years
77%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Cash & Cash Equivalents
CHf62.7m
CAGR 3-Years
46%
CAGR 5-Years
39%
CAGR 10-Years
10%
Siegfried Holding AG
SIX:SFZN
Cash & Cash Equivalents
CHf64.5m
CAGR 3-Years
3%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Cash & Cash Equivalents
CHf1.2B
CAGR 3-Years
34%
CAGR 5-Years
24%
CAGR 10-Years
16%
Tecan Group AG
SIX:TECN
Cash & Cash Equivalents
CHf108.3m
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Cash & Cash Equivalents
CHf85.1m
CAGR 3-Years
10%
CAGR 5-Years
191%
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
921.9m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
24.99 CHF
Overvaluation 11%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
95.7m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Cash & Cash Equivalents amounts to 95.7m EUR.

What is PolyPeptide Group AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
57%

Over the last year, the Cash & Cash Equivalents growth was 155%. The average annual Cash & Cash Equivalents growth rates for PolyPeptide Group AG have been 77% over the past three years , 57% over the past five years .

Back to Top